A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
University of California, San Francisco · Inserm · +9 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
941
total citations
- FWCI
- 51.06
- Percentile
- 100%
- References
- 48
Citations per year
Authors
13Topics & keywords
Topics
Keywords
- Belatacept
- Medicine
- Immunosuppression
- Urology
- Renal function
- Calcineurin
- Kidney transplantation
- Clinical endpoint
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.